Dietary supplement labeling with "internal inconsistency" is "red flag" -- FDA's Yetley.
This article was originally published in The Tan Sheet
Executive Summary
DIETARY SUPPLEMENT LABELS WITH "INTERNAL INCONSISTENCY" WOULD BE A "RED FLAG" attracting FDA's notice, Office of Special Nutritionals Director Elizabeth Yetley, PhD, said at a National Nutritional Foods Association symposium on structure/function claims in Washington, D.C. on Feb. 29. If a product has "a warning that says it's not a drug treatment and a name that implies that it is, then you have an internal inconsistency," Yetley explained.